A. Ebihara

发表

Original Article FDG-PET Imaging for Lymph Node Staging and Pathologic Tumor Response after Neoadjuvant Treatment of Non-small Cell Lung Cancer

T. Naruke, K. Suemasu, M. Kaji, 2006 .

Fluorodeoxyglucose Positron Emission Tomography Can Predict Pathological Tumor Stage and Proliferative Activity Determined by Ki-67 in Clinical Stage IA Lung Adenocarcinomas

T. Naruke, K. Yamazaki, Ken-ichi Watanabe, 2006 .

Severe Post-COVID-19 Organizing Pneumonia during Cancer Immunochemotherapy

K. Asano, I. Kuwahira, T. Oguma, 2022, Internal medicine.

The influence of early exposure to tobacco smoke for pulmonary disease

Takayuki Nakano, I. Kuwahira, A. Nagai, 2011 .

Sleep Disordered Breathing in Patients with Chronic Obstructive Pulmonary Disease

K. Suemasu, F. Sakamaki, Y. Yogo, 2005, COPD.

Superior sulcus lung cancer invading the ribs and brachial plexus successfully resected by modified trap-door thoracotomy after induction chemoradiotherapy.

T. Naruke, K. Suemasu, H. Horio, 2004, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

Subclinical visceral fat accumulation is a risk for lifestyle-related diseases and progression of atherosclerosis in Japanese adults:- results from a study of 94 healthy volunteers -

T. Imanishi, N. Ishii, C. Yamada, 2014 .

Hypobaric hypoxia is not a direct dyspnogenic factor in healthy individuals at rest

Takayuki Nakano, I. Kuwahira, A. Nagai, 2015, Respiratory Physiology & Neurobiology.

Indicator of arteriosclerosis in patients with COPD

C. Yamada, I. Kuwahira, A. Nagai, 2014 .

In a survey by the Ministry of Health, Labour and Welfare of Japan in 2012, chronic obstructive pulmonary disease (COPD)

C. Yamada, I. Kuwahira, A. Nagai, 2014 .

Relationship between early exposure to tobacco smoke and intima media thickness (IMT) in COPD patients

C. Yamada, I. Kuwahira, A. Nagai, 2014 .

FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.

T. Naruke, K. Suemasu, M. Kaji, 2006, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients.

K. Eguchi, T. Naruke, H. Nomori, 2006, Japanese journal of clinical oncology.

Analysis of continuous first-line treatment with docetaxel and carboplatin for advanced non-small cell lung cancer

K. Suemasu, F. Sakamaki, Y. Yogo, 2014, Oncology letters.

Abstract. The present study aimed to analyze the efficacy and safety of multiple cycles of docetaxel and carboplatin (CBDCA) as a first‐line treatment in patients with advanced non‐small cell lung cancer (NSCLC). Patients with stage III

K. Suemasu, F. Sakamaki, Y. Yogo, 2014 .

[F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas.

T. Naruke, K. Yamazaki, Ken-ichi Watanabe, 2006, Japanese journal of clinical oncology.